Influence of a prophylactic single dose of ciprofloxacin on the level of resistance of Escherichia coli to fluoroquinolones in urology.

No abstract is available for this paper.

• Publication year

  2000

• Venue

  International Journal of Antimicrobial Agents

• Publication date

  2000-07-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/S0924-8579(00)00182-5PMID 10926443
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Therapie der nosokomialen Pneumonie*

  2008cited by this paper
• DNA gyrase, topoisomerase IV, and the 4-quinolones

  1997cited by this paper
• [The therapy of nosocomial pneumonia].

  1997cited by this paper
• Adaptive mutations produce resistance to ciprofloxacin

  1997cited by this paper
• Adherence and the Pathogenesis of Urinary Tract Infection

  1997cited by this paper
• Fluoroquinolones in urinary tract infections. Proper and improper use.

  1996cited by this paper
• Characterization of clinical isolates of Escherichia coli showing high levels of fluoroquinolone resistance

  1996influential reference
• Multiple antibiotic resistance (mar) locus protects Escherichia coli from rapid cell killing by fluoroquinolones

  1996cited by this paper
• Emergence of fluoroquinolone-resistant Escherichia coli in fecal flora of cancer patients receiving norfloxacin prophylaxis

  1996cited by this paper
• A randomized prospective comparison of antibiotic tissue levels in the corpora cavernosa of patients undergoing penile prosthesis implantation using gentamicin plus cefazolin versus an oral fluoroquinolone for prophylaxis.

  1996cited by this paper
• AcrAB efflux pump plays a major role in the antibiotic resistance phenotype of Escherichia coli multiple-antibiotic-resistance (Mar) mutants

  1996cited by this paper
• Molecular epidemiology of fluoroquinolone-resistant Escherichia coli bloodstream isolates from patients admitted to European cancer centers

  1996cited by this paper
• Contributions of individual mechanisms to fluoroquinolone resistance in 36 Escherichia coli strains isolated from humans and animals

  1996cited by this paper
• 1995 Flemming Lecture. DNA topology and the global control of bacterial gene expression: implications for the regulation of virulence gene expression.

  1995cited by this paper
• Characterization of fluoroquinolone-resistant mutants of escherichia coli selected in vitro

  1994cited by this paper
• Emergence of fluoroquinolone-resistant Escherichia coli at a cancer center

  1994cited by this paper
• Susceptibility of clinical bacterial isolates to ciprofloxacin in the united states

  1994cited by this paper
• Bacteremia due to fluoroquinolone-resistantEscherichia coli in two immunocompromised patients

  1994cited by this paper
• Multiclonal emergence of ciprofloxacin-resistant clinical isolates of Escherichia coli and Klebsiella pneumoniae.

  1994cited by this paper
• Fluoroquinolone use and fluoroquinolone resistance: is there an association?

  1994cited by this paper
• Escherichia coli resistant to fluoroquinolones in patients with cancer and neutropenia.

  1994cited by this paper
• Mutations in the gyrA gene of a highly fluoroquinolone-resistant clinical isolate of Escherichia coli

  1993cited by this paper
• The emergence of highly fluoroquinolone-resistant Escherichia coli in community-acquired urinary tract infections.

  1992cited by this paper
• The molecular basis of quinolone action.

  1992cited by this paper
• Escherichia coli in fecal flora of healthy adults: serotypes, P and type 1C fimbriae, non-P mannose-resistant adhesins, and hemolytic activity.

  1992cited by this paper
• Association with prior fluoroquinolone therapy of widespread ciprofloxacin resistance among gram-negative isolates in a Veterans Affairs medical center

  1991cited by this paper
• Mode of action of the new quinolones: New data

  1991cited by this paper
• Mechanisms of quinolone resistance in a clinical isolate of Escherichia coli highly resistant to fluoroquinolones but susceptible to nalidixic acid

  1991cited by this paper
• First clinical isolate of highly fluoroquinolone-resistantEscherichia coli in scandanavia

  1990cited by this paper
• Isolation of fluoroquinolone-resistantEscherichia coli andKlebsiella pneumoniae from an infected hickman catheter

  1990cited by this paper
• Development of resistance to nalidixic acid and the fluoroquinolones after the introduction of norfloxacin and ofloxacin

  1988cited by this paper
• Single dose, oral antibiotic cover for transurethral prostatectomy.

  1988cited by this paper
• Summary of a Workshop on the Clone Concept in the Epidemiology, Taxonomy, and Evolution of the Enterobacteriaceae and other Bacteria

  1983cited by this paper
• From the national institutes of health. Summary of a workshop on the clone concept in the epidemiology, taxonomy, and evolution of the enterobacteriaceae and other bacteria.

  1983cited by this paper
• Antimicrobial resistance in hospital organisms and its relation to antibiotic use.

  1983cited by this paper

• Single-dose Versus 3-day Antimicrobial Prophylaxis in Transurethral Resection or Photoselective Vaporization of the Prostate: A Multicenter, Randomized, Placebo Controlled Trial (CITrUS Trial).

  2025cites this paper
• Antimicrobial prophylaxis protocol based on rectal swab culture before prostate biopsy to prevent infectious complications: a prospective randomized comparative study

  2024cites this paper
• Utilizing a Questionnaire to Implement a Risk-Based Antibiotic Prophylaxis Protocol for Transrectal Prostate Biopsy.

  2023cites this paper
• Prostatabiopsie – Infektionsprophylaxe sowie Vorbereitung des Patienten

  2023cites this paper
• Using a Multi-pronged Behavioral Intervention to Standardize Antibiotic Prophylaxis at the Time of Foley Catheter Removal After Radical Prostatectomy.

  2023cites this paper
• Short - versus - long course antibiotics in catheterized patients undergoing transurethral resection of prostate

  2021cites this paper
• A randomized trial regarding antimicrobial prophylaxis (AMP) in transurethral resection of bladder tumor (TURB)

  2021influential citation
• Prostatabiopsie 2021 – Was ist aktuell?

  2021cites this paper
• Antimicrobial selection for transurethral procedures across the United States: a state-by-state antibiogram evaluation.

  2021cites this paper
• Antimicrobial Prophylaxis in Transurethral Resection of the Prostate: Results of a Randomized Trial

  2021cites this paper
• The molecular mechanisms of fluoroquinolone resistance found in rectal swab isolates of Enterobacterales from men undergoing a transrectal prostate biopsy: the rationale for targeted prophylaxis

  2021cites this paper
• Effect of peritoneal lavage on bacterial isolates in 40 dogs with confirmed septic peritonitis.

  2019cites this paper
• Antibiotic prophylaxis in TURP: a prospective analysis concerning antibiotic stewardship and a potential reduction of antibiotic use in TURP

  2019cites this paper
• Surgical antibiotic prophylaxis

  2019cites this paper
• Prostate biopsy related infection – risk factors, prevention strategies and management approaches

  2018cites this paper
• Which antibiotic must be the first choice in high fever urinary infected patients related transrectal ultrasound guided prostate biopsy

  2018cites this paper
• Rectal culture-directed antibiotic prophylaxis before transrectal prostate biopsy: Reduced infectious complications and healthcare costs.

  2018cites this paper
• Profilaxis antibiótica «dirigida» por cultivos rectales antes de la biopsia prostática transrectal: reducción de complicaciones infecciosas y costes de atención sanitaria

  2018cites this paper
• Rectal culture-directed antibiotic prophylaxis before transrectal prostate biopsy: Reduced infectious complications and healthcare costs

  2018cites this paper
• A Comparative Study of Effect of Single-Dose Prophylactic Antibiotic versus Conventional Antibiotic Therapy in Selected Clean Surgical Cases in A Tertiary Care Centre

  2018cites this paper
• Antibiotics: Prophylactic and Therapeutics

  2017cites this paper
• Prostate Biopsy-related Infection: A Systematic Review of Risk Factors, Prevention Strategies, and Management Approaches.

  2017cites this paper
• Management of Infective Complications Following Prostate Biopsy

  2016cites this paper
• Antimikrobielle und antiinfektiöse Maßnahmen

  2016cites this paper
• Rectal swab testing before prostate biopsy: experience in a VA Medical Center urology practice

  2015cites this paper
• Chapter 175 – Antimicrobial Use in the Critical Care Patient

  2015cites this paper
• Clinical Study Quinolone Prophylaxis in Transrectal Ultrasound Guided Prostate Biopsy : An Eight-Year Single Center Experience

  2015cites this paper
• Infectious complications after prostate biopsy: Time to rethink our clinical practice

  2015cites this paper
• Preprostate Biopsy Rectal Culture and Postbiopsy Sepsis.

  2015cites this paper
• Reducing infection rates after prostate biopsy

  2014cites this paper
• Antibiotic prophylaxis in craniotomy: a review

  2014cites this paper
• Infektions- und Sepsisprävention bei Prostatabiopsie

  2013cites this paper
• Infective complications after prostate biopsy: outcome of the Global Prevalence Study of Infections in Urology (GPIU) 2010 and 2011, a prospective multinational multicentre prostate biopsy study.

  2013cites this paper
• Quinolone Prophylaxis in Transrectal Ultrasound Guided Prostate Biopsy: An Eight-Year Single Center Experience

  2013cites this paper
• Defining Relatedness in Studies of Transmission of Antimicrobial-Resistant Organisms Variability in Definitions across Studies and Impact of Different Approaches on Study Conclusions

  2013cites this paper
• Reemergence of Established Pathogens in the 21st Century

  2013cites this paper
• Infection in Patients Undergoing Transrectal Ultrasound Guided Prostate Biopsy

  2013cites this paper
• Early infectious complications with transponder placement for external beam radiation therapy for prostate cancer

  2012cites this paper
• Single dose antibiotic prophylaxis in clean soft tissue procedures

  2012cites this paper
• EARLY INFECTIOUS COMPLICATIONS WITH TRANSPONDER PLACEMENT FOR EXTERNAL BEAM RADIATION THERAPY FOR PROSTATE CANCER

  2012cites this paper
• Low‐power holmium:YAG laser urethrotomy for urethral stricture disease: Comparison of outcomes with the cold‐knife technique

  2011cites this paper
• Emergence of fluoroquinolone-resistant Escherichia coli as cause of postprostate biopsy infection: implications for prophylaxis and treatment.

  2011cites this paper
• Interpreting culture and susceptibility data in critical care: perks and pitfalls.

  2010cites this paper
• Sepsis due to fluoroquinolone-resistant Escherichia coli after transrectal ultrasound-guided prostate needle biopsy.

  2009cites this paper
• Bacterial sepsis after prostate biopsy--a new perspective.

  2009cites this paper
• Community-acquired Urinary Tract Infections: Treatment, Outcomes, and Antimicrobial Resistance

  2009cites this paper
• Evidence‐based prescription of antibiotics in urology: a 5‐year review of microbiology

  2009cites this paper
• Chapter 194 – Antimicrobial use in the Critical Care Patient

  2009cites this paper
• État de l'art : antibioprophylaxie pour les biopsies de prostate

  2008cites this paper
• Trends in antimicrobial susceptibility of Escherichia coli isolates from urology services in The Netherlands (1998-2005).

  2008cites this paper
• Nitrofurantoin: the return of an old friend in the wake of growing resistance

  2008cites this paper
• Resistenza ai fluorochinoloni in Escherichia coli isolati da infezioni delle vie urinarie (IVU) in pazienti ospedalizzati in unità di terapia intensiva (UTI).

  2007influential citation
• Japanese guidelines for prevention of perioperative infections in urological field

  2007cites this paper
• Comparison of pharmacodynamic and pharmacokinetic indices of efficacy for 5 fluoroquinolones toward pathogens of dogs and cats.

  2006cites this paper
• Principles of antimicrobial therapy.

  2006cites this paper
• Isolation of fluoroquinolone-resistant rectal Escherichia coli after treatment of acute uncomplicated cystitis.

  2005cites this paper
• Acute uncomplicated cystitis in an era of increasing antibiotic resistance: a proposed approach to empirical therapy.

  2004cites this paper
• Multi-resistant Enterobacteriaceae in Hospital Practice

  2004cites this paper
• Fluoroquinolones: action and resistance.

  2003cites this paper
• Fluoroquinolones and resistance in the treatment of uncomplicated urinary tract infection.

  2003cites this paper
• Epidemiological analysis of the spread of pathogens from a urological ward using genotypic, phenotypic and clinical parameters.

  2002cites this paper